Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $22.46 +0.63 (+2.89%) As of 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatings Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1Bny Mellon Cash Reserve UsdN/A1.71%130,5672SANASana Biotechnology$2.92-7.6%1.49%34,8493VIRVir Biotechnology$10.42+3.1%1.26%9,5684CVACCureVac$4.14+1.0%1.22%22,2165ORICORIC Pharmaceuticals$10.00+4.4%1.11%8,4346LQDALiquidia$13.62+5.7%1.06%6,4577ARQTArcutis Biotherapeutics$13.08+3.2%1.05%5,8038ZYMEZymeworks$14.29+3.0%1.03%5,6339OMEROmeros$9.15-1.9%1.01%8,37310TYRATyra Biosciences$15.91-1.7%0.99%4,686 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11SRRKScholar Rock$44.88+4.1%0.98%1,70712SMMTSummit Therapeutics$22.10+16.1%0.95%3,97913CGONCG Oncology$30.00+3.2%0.94%2,46314XENEXenon Pharmaceuticals$38.98+1.2%0.94%1,80215ABCLAbCellera Biologics$3.06+3.0%0.93%24,09916ANABAnaptysBio$16.88+6.5%0.93%4,73317SLNOSoleno Therapeutics$49.17+4.9%0.93%1,53618PCVXVaxcyte$88.17+3.4%0.93%80919PRAXPraxis Precision Medicines$78.26+10.9%0.92%1,00120COGTCogent Biosciences$8.20+2.1%0.91%8,52421ITOSiTeos Therapeutics$8.06+0.8%0.91%8,94822TNGXTango Therapeutics$3.08+8.1%0.91%24,94523VERVVerve Therapeutics$6.57+7.0%0.91%11,41124ARCTArcturus Therapeutics$16.41-2.3%0.90%4,05125NUVBNuvation Bio$2.60+3.4%0.90%27,03126SNDXSyndax Pharmaceuticals$13.67+4.5%0.90%5,27827EWTXEdgewise Therapeutics$27.39+4.3%0.89%2,52628ELVNEnliven Therapeutics$22.00+2.5%0.89%3,09129KYMRKymera Therapeutics$43.70+7.6%0.89%1,68630MRUSMerus$39.74+0.7%0.89%1,71631PRMEPrime Medicine$2.91+0.7%0.89%23,61832PRTAProthena$14.11+2.5%0.89%5,14833AVBPArriVent BioPharma$25.31+3.7%0.88%2,74734CAPRCapricor Therapeutics$14.06+2.6%0.88%4,95735RNACCartesian Therapeutics$19.85+2.9%0.88%3,53336NRIXNurix Therapeutics$19.60+2.4%0.88%3,45837QUREuniQure$14.91+6.1%0.88%4,72138VRDNViridian Therapeutics$18.41+1.5%0.88%3,95239XERSXeris Biopharma$3.34+4.4%0.88%20,91040CYTKCytokinetics$45.82+0.2%0.87%1,415URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now41IRONDisc Medicine$60.52+3.9%0.87%1,10642MNMDMind Medicine (MindMed)$7.18+0.3%0.87%10,12743NAMSNewAmsterdam Pharma$23.70+0.6%0.87%2,83444DNLIDenali Therapeutics$23.04+5.1%0.86%3,02945PHVSPharvaris$19.12+4.1%0.86%3,73846RXRXRecursion Pharmaceuticals$6.88+5.4%0.86%10,18547ALLOAllogene Therapeutics$1.84+1.1%0.85%35,19448ANNXAnnexon$4.17-0.7%0.85%15,76349EYPTEyePoint Pharmaceuticals$7.63+2.0%0.85%8,95350CATXPerspective Therapeutics$3.52+2.6%0.85%20,487 Geographic ExposureUnited States86.7%Canada2.7%Netherlands2.4%Ireland0.9%Virgin Islands, British0.8%Singapore0.8%Cayman Islands0.7%Currency ExposureUSD100.0%Sector ExposureHealth Care25.0%Energy0.8%Consumer Discretionary0.7%Industry ExposureBiotechnology23.5%Diversified Consumer Services1.5%Renewable Energy0.8%Pharmaceuticals0.8%SubIndustry ExposureBiotechnology19.2%Pharmaceuticals2.3%Renewable Energy Equipment0.8%Coupon Exposure0-21.7% Related Companies and Tools Related Companies JDOC Portfolio BIS Portfolio PILL Portfolio HYLG Portfolio LGHT Portfolio RXD Portfolio FTXH Portfolio MEDX Portfolio MEDI Portfolio GDOC Portfolio This page (NYSEARCA:BBC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.